|
|---|
|
| 相关主题 |
|---|
| ● Eb1a 被RFE了 | ● (GONE)审稿机会——医学数据统计 IF 5 | | ● [gone]Rviewer oppertunities (statistics/biostatiatics) | ● Discuss TOP 25 Hottest Articles? | | ● TSC RD 10/7报绿，timeline, 背景 | ● 有发表这几个期刊的朋友看看咋吹啊！！ | | ● 转审稿－Adenoids, B cell response/immunoglobulin productio | ● 审稿机会：Annals of Allergy, Asthma & Immunology | | ● 转审稿, Cohort Study, risk factor, statistical analysis方向 | ● [Reviewer needed] gone! | | ● NSC 6.3RD 主副同绿 | ● ［审稿邀请］Annals of Allergy, Asthma & Immunology | | ● SR结果with an adjudicating officer,快了吗？先发点包子 | ● ［审稿邀请］Annals of Allergy, Asthma & Immunology | | ● 求审稿，生物方向looking for review opportunities | ● [Reviewers needed] 方向：Asthma, Allergy, Inflammation |
|
|
|
|
|
I********e
发帖数: 1155 | 1 杂志 Contemporary Clinical Trials, Contemporary Clinical Trials,
每年有100-200篇文章需要审稿人，感兴趣请给我私信。
Papers needing reviewers now:
1) “iAlegrate!”—A Culturally Adapted Positive Psychological Intervention
for Hispanics/Latinos with Hypertension: Rationale, Design, and Methods
2) A Review of the Technical Aspects of Data Management Systems in Clinical
Trials
3) A statistical approach to identify optimal inclusion criteria: an
application to acute stroke clinical trials
4) Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen
in Norway: Protocol for validation and a prospective cohort study
5) Knowledge and use of recruitment support tools among study coordinators
at an academic medical center: The Novel Approaches to Recruitment Planning
Study
6) Participant recruitment into a community-based diabetes prevention trial
in India: learnings from the Kerala Diabetes Prevention Program
7) Prognostic Significance of Lymph Node Yield and Lymph Node Ratio in
Patients Affected by Squamous Cell Carcinoma of the Oral Cavity and
Oropharynx: a protocol for a Prospective, Multicenter, Observational Study
8) Design and Baseline Characteristics of a Low-income Urban Cohort of
Children with Asthma: The Asthma Action at Erie Trial
9) Solving Insomnia Electronically: Sleep Treatment for Asthma (SIESTA): A
study protocol for a randomized controlled trial
10) The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase
III, randomized trial of second intravenous immunoglobulin versus infliximab
for resistant Kawasaki disease |
|
|
|
|
|
|
|
